Hjem › Sklerodermi › Florida › Miami
Sklerodermi kliniske forsøg i Miami, FL
4 studier for Sklerodermi søger deltagere på steder i og omkring Miami (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
- GSK Investigational Site, Miami
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RekruttererFase 2
- Artiva Investigational Site Miami, Miami
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Nicklaus Children's Hospital, Miami
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekruttererFase 2
- aTyr Investigative Site, Miami
Sklerodermi forsøg i andre byer
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Chicago, IL10 studier
- Houston, TX9 studier
- Boston, MA7 studier
- Durham, NC7 studier
- Los Angeles, CA7 studier
- New Orleans, LA6 studier
- Baltimore, MD6 studier
- Philadelphia, PA6 studier
- Dallas, TX5 studier
- Pittsburgh, PA5 studier
Andre studier i Miami
- Brystkræft42 studier
- Kræft (alle typer)36 studier
- Ikke-småcellet lungecancer31 studier
- Prostatakræft27 studier
- Overvægt27 studier
- Akut myeloid leukæmi24 studier
- Metastatisk cancer24 studier
- Ægstockræft23 studier
- Overvægt23 studier
- Multipelt myelom21 studier
- Ulcerøs colitis21 studier
- Alzheimers sygdom20 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.